LoRusso P, Hamilton E, Ma C, Vidula N, et al. A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer. Clin Breast Cancer 2021 Aug 20. pii: S1526-8209(21)00240.
PMID: 34565686